The U.S. Preventive Services Task Force has posted a draft recommendation statement and published a final evidence summary on low-dose aspirin for the prevention of morbidity and mortality from preeclampsia.
The task force recommends use of low-dose aspirin (81 mg/day) after 12 weeks of pregnancy in women who are at high risk for preeclampsia. Before developing the final recommendation, the task force will accept public comments until May 5.
This recommendation applies to pregnant women who are at high risk for preeclampsia and who do not show signs or symptoms of the condition and havent had any health problems from using aspirin in the past. Preeclampsia is one of the leading causes of health complications for expectant mothers and their babies, affecting about 4% of all pregnancies in the U.S.
Preeclampsia can cause serious health problems for both expectant mothers and their babies, task force member Jessica Herzstein, MD, MPH, said in a news release. The good news is that pregnant women who are at high risk for developing preeclampsia can take a low dosage of aspirin daily to help to prevent the condition. This can result in better health outcomes for both the mother and the baby.
For women at high risk, low-dose aspirin has been found to reduce the risk of preeclampsia, premature birth and intrauterine growth restriction.
Only a small percentage of pregnant women are at high risk for preeclampsia, task force chairman Michael L. LeFevre, MD, MSPH, said in the news release. Before taking aspirin, pregnant women should talk to their doctor or nurse to determine their risk and discuss if taking aspirin is right for them.
Read the recommendation and comment until May 5: http://www.uspreventiveservicestaskforce.org/draftrec.htm